ArticleCell reports. Medicine2026

Efficacy and safety of autologous CD5-KO anti-CD5 CAR-T cells in relapsed/refractory CD5

Jiali Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.